We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Kinase Assay Optimized

By Biotechdaily staff writers
Posted on 08 May 2007
A flexible and adaptable homogeneous technology for high-throughput screening (HTS) and ultra HTS (uHTS) was designed specifically for developing and optimizing sensitive assays for a variety of drug discovery targets, with a particular focus on applications for a wide range of kinase targets.

PerkinElmer, Inc. More...
(Waltham, MA, USA), announced that it has expanded its successful portfolio of HTS Lance assays with the release of Lance Ultra. The improved time-resolved fluorescence resonance energy transfer (TR-FRET) technology accelerates speed and precision of kinase assay development and optimization.

"Protein kinases regulate several important functions within cells, such as growth, proliferation, and cell adhesion, making it one of the most important areas of study in today's pharmaceutical and biotech laboratories,” said Dr. Richard Eglen, vice president and general manager of the Discovery and Research Reagents business of PerkinElmer Life and Analytical Sciences. "The addition of Lance Ultra to PerkinElmer's broad offering of TR-FRET assay tools creates one of the industry's largest portfolios targeting high value functional biochemical and cell based assays.”

Lance Ultra utilizes ULight, an innovative, low-molecular weight red-shifted fluorescent dye that greatly enhances the performance of TR-FRET assays by increasing the range of targets that can be identified. Dr. Eglen said, "Dysregulation of kinase activity plays causal roles in many human diseases, making kinases one of today's most important drug discovery target classes.”

Lance Ultra reagents are specifically engineered for the precise development and optimization of kinase and enzyme assays, as well as for monitoring protein-protein interactions. Ultra high throughput screening applications such as Lance Ultra are easily adapted to any TR-FRET capable plate reader such as the PerkinElmer ViewLux uHTS imaging system or EnVision multimode reader, enabling greatly improved precision and remarkable throughput.

In addition to its broad range of traditional Lance technologies, PerkinElmer has significantly enhanced its custom reagents service, offering expert labeling of a wide variety of peptides, proteins and antibodies with PerkinElmer's proprietary europium and lanthanide chelate donor dyes, and ULight or allophycocyanin (APC) acceptor dyes.


Related Links:
PerkinElmer

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.